Conditional knockout of the NSD2 gene in mouse intestinal epithelial cells inhibits colorectal cancer progression
Animal Models and Experimental Medicine · 2025-02 · 8 (2) · 322-331
DOI: 10.1002/ame2.12392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 23.02.2024. Verfasst von Mengyuan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Me…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Histone-Lysine N-Methyltransferase, Epithelial Cells, Intestinal Mucosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Higher Education Discipline Innovation Project, National Key Research and Development Program of China, Special Research Fund for Central Universities, Peking Union Medical College.
Abstract (Originalsprache)
Background
Nuclear receptor‐binding SET domain 2 (NSD2) is a histone methyltransferase, that catalyzes dimethylation of lysine 36 of histone 3 (H3K36me2) and is associated with active transcription of a series of genes. NSD2 is overexpressed in multiple types of solid human tumors and has been proven to be related to unfavorable prognosis in several types of tumors.
Methods
We established a mouse model in which the NSD2 gene was conditionally knocked out in intestinal epithelial cells. We used azoxymethane and dextran sodium sulfate to chemically induce murine colorectal cancer. The development of colorectal tumors were investigated using post‐necropsy quantification, immunohistochemistry, and enzyme‐linked immunosorbent assay (ELISA).
Results
Compared with wild‐type (WT) control mice, NSD2 fl/fl ‐Vil1‐Cre mice exhibited significantly decreased tumor numbers, histopathological changes, and cytokine expression in colorectal tumors.
Conclusions
Conditional knockout of NSD2 in intestinal epithelial cells significantly inhibits colorectal cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Beijing, China.
- Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Beijing, China.
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.
ORCID-Profile: Mengyuan Li
Förderung
- Higher Education Discipline Innovation Project
- National Key Research and Development Program of China
- Special Research Fund for Central Universities, Peking Union Medical College
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Li, M., Chen, H., Yang, X., Zhang, W., Ma, C., Wang, Q., Wang, X., & Gao, R. (2025). Conditional knockout of the NSD2 gene in mouse intestinal epithelial cells inhibits colorectal cancer progression. Animal Models and Experimental Medicine, 8(2), 322-331. https://doi.org/10.1002/ame2.12392
Vancouver
Li M, Chen H, Yang X, Zhang W, Ma C, Wang Q, et al. Conditional knockout of the NSD2 gene in mouse intestinal epithelial cells inhibits colorectal cancer progression. Animal Models and Experimental Medicine. 2025;8(2):322-331. doi:10.1002/ame2.12392
BibTeX
@article{Li2025,
author = {Li, Mengyuan and Chen, Hanxue and Yang, Xingjiu and Zhang, Wenlong and Ma, Chengyan and Wang, Qinghong and Wang, Xinpei and Gao, Ran},
title = {Conditional knockout of the NSD2 gene in mouse intestinal epithelial cells inhibits colorectal cancer progression},
journal = {Animal Models and Experimental Medicine},
year = {2025},
volume = {8},
number = {2},
pages = {322--331},
doi = {10.1002/ame2.12392}
}
EUVIMED